JUBLPHARMA — Jubilant Pharmova Cashflow Statement
0.000.00%
Last trade - 00:00
- IN₹105.30bn
- IN₹130.92bn
- IN₹62.82bn
- 90
- 14
- 98
- 81
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 9,038 | 12,105 | 8,711 | 6,304 | 278 |
Depreciation | |||||
Non-Cash Items | 4,906 | 2,988 | 6,058 | 1,978 | 2,288 |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -6,438 | -4,283 | -2,212 | -3,724 | -1,500 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 11,215 | 15,429 | 17,073 | 8,375 | 6,607 |
Capital Expenditures | -6,559 | -5,742 | -5,275 | -6,000 | -8,144 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -3,559 | 2,472 | -2,115 | 2,196 | 2,700 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -10,118 | -3,270 | -7,390 | -3,804 | -5,444 |
Financing Cash Flow Items | -2,155 | -3,250 | -2,922 | -1,349 | -2,342 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 6,574 | -10,504 | -17,094 | -326 | -1,567 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 7,612 | 2,254 | -7,289 | 4,819 | 301 |